Parker Waichman LLP

New Study Finds Public May Misunderstand FDA “Breakthrough” Designation for New Drugs

In a newly published article in JAMA Internal Medicine, researchers say the U.S. Food and Drug Administration (FDA) should be cautious in using words like “breakthrough” and “promising” when making announcements about new drugs because the public may not understand the agency’s usage. “Unless patients understand the FDA’s usage of ‘breakthrough,’ they may have unwarranted […]

In a newly published article in JAMA Internal Medicine, researchers say the U.S. Food and Drug Administration (FDA) should be cautious in using words like “breakthrough” and “promising” when making announcements about new drugs because the public may not understand the agency’s usage.

“Unless patients understand the FDA’s usage of ‘breakthrough,’ they may have unwarranted confidence in the evidence supporting drug claims,” the researchers wrote. The public may understand a “breakthrough” to be an important advance, but to the FDA, the designation does not necessarily mean that a drug is highly effective or that it will help patients live longer, according to researchers at Dartmouth College’s Geisel School of Medicine and Carnegie Mellon University, Live Science reports.

To the FDA, a “breakthrough therapy” is a drug that meets specific criteria, including that it treats a “serious or life-threatening condition” and “may demonstrate substantial improvement over existing therapies.” Breakthrough therapies undergo a faster FDA review process and are often approved more quickly, with additional evidence on the drug’s effectiveness to come later. When a breakthrough therapy is approved, FDA news releases often use the word “breakthrough,” and about half of the news releases also use the word “promising.”

For the JAMA Internal Medicine study, the researchers asked about 600 American adults, to read and give judgments of short descriptions of a hypothetical drug to treat lung cancer, Live Science reports. The descriptions were based on actual FDA press releases. The first description presented just the facts, stating, for example, that half of participants in a trial of the drug had their tumors shrink, and that this effect lasted about seven months. The second description called the medication a “breakthrough” drug, and the third described the drug as “promising.”

About 10 percent of the study participants who read only the facts thought the drug was “very effective” at treating lung cancer. Their opinion of the drug’s effectiveness increased to 22 to 25 percent when the words “promising” or “breakthrough” were used in the description, according to Live Science. Forty-three percent of participants who read just the facts judged the evidence supporting the drug as “strong,” but the percentage increased to 57 to 60 percent when “promising” or “breakthrough” were in the description.

The words “breakthrough” and “promising” increased belief in a drug’s effectiveness and in the strength of the supporting evidence, the researchers say. The FDA is not required to use those words in news releases, and the researchers suggest that neutral terms in press releases “might help consumers make more accurate judgments about these drugs,” according to Live Science.

Dr. Rita F. Redberg and Dr. Joseph S. Ross, editors of JAMA Internal Medicine, wrote in an editorial accompanying the study that these terms might give patients “spurious hope” for a miracle cure. They recommend that Congress and the FDA abandon “terminology like ‘breakthrough’ and focus on strengthening the evidentiary requirements for meaningful clinical data to ensure the promise of new drugs and devices.”

 

 

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Parker Waichman was extremely professional and helpful in handling our WTC case. Benita Rollis, in particular, was amazing in helping us complete all the necessary steps and paper work for our claim. She was always quick to return phone calls and reach out to keep us posted on how things were progressing. Not only was Benita efficient and professional, she was also very compassionate in helping us through the emotional side of this long process. Carolyn Corcoran & Family
Robert Harris
a year ago
5 Star Reviews 150
The law firm worked with me on a victim compensation fund. Christina Morace was the paralegal and through the long process she called me to keep me up to date. She let me know what paperwork was coming and what it meant. She also called to explain the time table for each part. I did not have to wonder about what was happening. I really appreciate her work and the others at Parker Waichman.
Shauna N
2 years ago
5 Star Reviews 150
I worked with Parker waichman on a personal injury lawsuit. They made the process easy and got me a fair amount of money. Alex and Kathy were both super helpful and patient during the whole process. I'd definitely recommend them.
Kelly Curto
a year ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard, Suite 108
Bonita Springs, FL 34134
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747